Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised …
Background Evidence of comparative benefits of long-acting injectable antipsychotics (LAIs)
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …
Controversies surrounding the use of long-acting injectable antipsychotic medications for the treatment of patients with schizophrenia
Schizophrenia is a serious mental illness that requires continuous and effective long-term
management to reduce symptoms, improve quality of life, and prevent relapse. Oral …
management to reduce symptoms, improve quality of life, and prevent relapse. Oral …
Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders
This mirror-image study aimed to evaluate the real-life effectiveness of long-acting injectable
antipsychotics (LAI) in schizophrenia. Patients with schizophrenia initiating LAIs January …
antipsychotics (LAI) in schizophrenia. Patients with schizophrenia initiating LAIs January …
Relapse rates with paliperidone palmitate in adult patients with schizophrenia: results for the 6-month formulation from an open-label extension study compared to real …
I Turkoz, M Daskiran, U Siddiqui… - International Journal …, 2024 - academic.oup.com
Background The 3 paliperidone palmitate (PP) long-acting injectable antipsychotic
formulations, PP 1-month (PP1M), PP 3-month (PP3M), and PP 6-month (PP6M), have …
formulations, PP 1-month (PP1M), PP 3-month (PP3M), and PP 6-month (PP6M), have …
Long-acting injectable antipsychotic treatment for schizophrenia in Asian population: a sco** review
N Ma, L Zhang, W Zhang, Y He, C Ye… - … Disease and Treatment, 2023 - Taylor & Francis
Evidence of comparative benefits of long-acting injectable (LAI) antipsychotics in Asian
patients with schizophrenia has been inconsistent. This sco** review aimed to synthesize …
patients with schizophrenia has been inconsistent. This sco** review aimed to synthesize …
The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review …
Long‐acting injectable (LAI) antipsychotic medications may be an important modality of
reducing costs, improving symptoms, and fostering quality of life outcomes for those with …
reducing costs, improving symptoms, and fostering quality of life outcomes for those with …
Achieving long-term goals through early personalized management of schizophrenia: expert opinion on the role of a new fast-onset long-acting injectable …
Definition of an appropriate and personalized treatment plan focused on long-term
outcomes is crucial in the management of schizophrenia. Following review of the literature, a …
outcomes is crucial in the management of schizophrenia. Following review of the literature, a …
Unveiling the actual cost of Schizophrenia: An Activity‐Based Costing (ABC) approach
Background Despite its relatively low lifetime prevalence, the health, social, and economic
burden of Schizophrenia is very significant. In the last 10 years, several studies have …
burden of Schizophrenia is very significant. In the last 10 years, several studies have …
Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study
C Montemagni, E Del Favero… - Therapeutic …, 2022 - journals.sagepub.com
Background: Partial adherence to antipsychotics is the most common cause of relapses and
rehospitalization in patients with schizophrenia (SZ), leading to higher health care costs and …
rehospitalization in patients with schizophrenia (SZ), leading to higher health care costs and …
Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study
R Sancho-Echeverria, C Aymerich… - Therapeutic …, 2024 - journals.sagepub.com
Background: The effectiveness of long-acting injectable (LAI) antipsychotics in preventing
relapses of first-episode psychosis is currently debated. Objectives: The study aimed to …
relapses of first-episode psychosis is currently debated. Objectives: The study aimed to …